While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

Drs Kathy D. Miller and Heather A. Parsons explore the complexities and evolving strategies in managing HER2+ oligometastatic ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug Administration in July.

Drug treatments for blood cancers have evolved. In the past, myeloma patients received two drugs in sequence—two after two.

The prostate is a small gland in males that aids in reproduction. Prostate cancer is one of the most common types of cancer, ...

Prostate cancer, which develops in the prostate gland, primarily affects older men, but younger men with a family history are ...

What is ovarian cancer? It's a cancer that strikes a woman's ovaries, the small almond-shaped organs that produce and release ...

Blood tests for cancer detection, known as liquid biopsies, can still be unreliable, but progress is being made. Competition between different diagnostics companies is also intensifying.

Dandelion is regarded as a stubborn weed but has diverse medicinal properties. Naturopathic practitioners have used dandelion ...